Katherine Hunt Brendish
-
-
6161 E. Mayo Blvd. Phoenix, AZ 85054
-
Mail code: 9020Campus: Scottsdale
-
Katherine Hunt Brendish is a director and clinical professor in the College of Health Solutions. She joined ASU in 2019, coming from the Mayo Clinic School of Medicine, where she was an assistant professor in the Department of Clinical Genomics. She received her doctorate in biology and society from Arizona State University in 2013. She is a Certified Genetic Counselor (CGC) with the American Board of Genetic Counseling.
Brendish is an experienced certified genetic counselor and is developing degree programs that prepare students to counsel individuals and families on the complex issues surrounding genetic testing.
- Ph.D. Biology and Society, Arizona State University 2013
- Master's degree. Genetic Counseling, Northwestern University 1995
- Bachelor's degree. English Literature, Biology, Chemistry, The University of Arizona 1991
Personalized Medicine
Informed consent protocols for whole genome sequencing
Understanding the value of genetic counseling in genomic medicine
Peer-reviewed Articles
1. Trepanier A, Ahrens M, McKinnon W, Peters J, Stopfer J, Grumet S, Hunt K, et al. Genetic cancer risk assessment and counseling: Recommendation of the National Society of Genetic Counselor. Journal of Genetic Counseling. 2004; 3(2):83-114.
2. Brewer MA, Utzinger U, Barton JK, Hoying JB, Kirkpatrick ND, Brands WR, Davis JR, Hunt K, et al. Imagine of the ovary. Technology in Cancer Research and Treatment. 2004; 3(6):617-27.
3. Lindor NM, Lindor R, Apicella C, Dowty J, Ashley A, Hunt K, et al. Predicting BRCA1 and BRCA2 gene mutation carriers; comparison of LAMBA, BRCAPRO, myriad II and modified couch models. Familial Cancer. 2007; 6:473-482.
4. Lindor NM, Johnson KJ, Harvey H, Shane Pankratz V, Domchek SM, Hunt K, et al. Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study. Familial Cancer. 2010 Dec; 9(4):495-502.
5. Pipe T, Fisher C, Levey S, Hunt K, Wood A. Coping with breast cancer and long-term health promotion: examining maladaptive communication between mothers and young-adult daughters. Oncology Nursing Forum. 2011 March; 38(2):E125.
6. Raskin L, Schwenter F, Freytsis M, Tischkowitz M, Wong N, Chong G, Narod SA, Levine DA, Thibodeau SN, Hunt KS, et al. Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome. Clin Genet. 2011 Jun; 79(6):512-22.
7. Files JA, Frey KA, David PS, Hunt KS, et al. Developing a Reproductive Live Plan. Journal of Midwifery & Women’s Health. 2011 Sep-Oct;56(5):468-74.
8. Bronson DR, Culver JO, Skrzynia C, Senter LA, Peters JA, Costalas JW, Callif-Daley F, Grumet SC, Hunt KS, et al. Essential elements of genetic cancer risk assessment, counseling and testing: Updated recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling. 2012 Apr; 21(2):151-161.
9. Roberts ME, Riegert-Johnson DL, Thomas BC, Thomas CS, Heckman MG, Krishna M, DiCaudo DJ, Bridges AG, Hunt KS, et al. Screening for muir-torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms. Journal of Genetic Counseling. 2013 Jun;22(3):393-405.
10. Caselli R, Langbaum J, Marchant G, Lindor R, Hunt K, Robert J. An internet-based survey assessing public attitudes about preclinical testing for Alzheimer’s disease. Alzheimer’s and Dementia. 2013 Jul;9(4) SP545-P546.
11. Borad MJ, Champion MD, Egan JB, Liang WS, Fonseca R, Bryce AH, McCullough AE, Barrett MT, Hunt K, et al. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinomas. PLoS Genetics. 2014 Feb;http://dx.doi.org/10.1371/journal.pgen.1004135.
12. Caselli RJ, Langbaum JB, Marchant GE, Lindor RA, Hunt KS, et al. Predictive testing for Alzheimer’s disease: suicidal ideation in healthy participants. Alzheimer’s and Dementia. 2014 Jul;10(4)SP610.
13. Caselli RJ, Langbaum J, Marchant GE, Lindor RA, Hunt KS, et al. Public perceptions of presymptomatic testing for Alzheimer’s disease. Mayo Clinic Proceedings. 2014 Oct;89(10):1389-96.
Educating Oncologists and their Staff about Cancer Genetics Issues- grant awarded by Mountain States Regional Genetics Network; July 1998; Principle Investigator
Risk Reducing Behaviors of Women at Risk for Breast/Ovarian Cancer- Funded by Better Than Ever. Arizona Cancer Center; July 2003; Co-Investigator
Biomarkers for Alzheimer’s Disease: Defining Expert and Public Expectations- Funded by ASU Mayo Seed Grant; Nov. 2010-Dec 2011; Co-Investigator
Courses
2023 Spring
| Course Number | Course Title |
|---|---|
| SHS 494 | Special Topics |
| CHS 492 | Honors Directed Study |
| SHS 544 | Genetic Health/Disease/Society |
| GCO 650 | Cancer/Cardiac Genom/Prec Med |
| GCO 620 | Genetic Counseling Techniques |
| GCO 691 | Seminar |
2022 Fall
| Course Number | Course Title |
|---|---|
| GCO 540 | Foundation Medical Genetics |
| GCO 691 | Seminar |
2022 Spring
| Course Number | Course Title |
|---|---|
| SHS 494 | Special Topics |
| SHS 598 | Special Topics |
2021 Spring
| Course Number | Course Title |
|---|---|
| CHS 493 | Honors Thesis |
| SHS 598 | Special Topics |
| SHS 494 | Special Topics |
2020 Fall
| Course Number | Course Title |
|---|---|
| CHS 492 | Honors Directed Study |
Graduated with Honors in English Literature – University of Arizona, 1991
Phi Kappa Phi Honor Society – Arizona State University, 2011 - 2013
Journal Editorial Responsibilities
National Society of Genetic Counselors; Perspectives; Editorial Staff, 1997 - 2007
Journal of Genetic Counseling; Reviewer, 1998 - 2000
Professional Memberships & Services
National Society of Genetic Counselors, Member 1993- Present
- Student Mentor, 1998- 2004
- Practice Guidelines Committee, Lead Author, Genetic Counseling Clinical Documentation Resource; 2017- Present
- Cancer SIG and Education SIG, Member 2000- Present
- Community Voices, Column Writer, 1997 - 2007
- Ethics Sub-Committee, Appointed Member (Chairman, 1998 - 1999)
- Region V Representative, 1999 - 2000
Genetic Counselor - St. Luke’s Hospital, St. Louis, MO; 1995 - 1997
Genetic Counselor – University of New Mexico School of Medicine, Department of Pediatrics, Albuquerque, NM; 1997 - 1998
Genetic Counselor (Senior Genetic Counselor/Lecturer) – University of New Mexico School of Medicine, Department of OB/GYN, Albuquerque, NM; 1997 - 2002
Genetic Counselor – Southwest Perinatology, Albuquerque, NM; 2001 - 2002
Specialist, Teratology Information – University of Arizona, Department of Pharmacy, Tucson, AZ; 2002 - 2004
Genetic Counselor/Senior Research Specialist – Arizona Cancer Center, Tucson, AZ; 2002 - 2004
Consultant – Cengage Learning, GALE Encyclopedia of Genetic Disorders; 2014- 2015
Genetic Counselor/Coordinator – Mayo Clinic, Phoenix AZ; 2004- 2017
Genetic Counselor, IMPACT program – Thermo Fisher Scientific; 2017– 2019
Community Memberships & Services
Minkoff Center for Jewish Genetics; Director, Founder3-BRCA Screening, 01/2018 - Present
Jewish Genetic Disease Education & Screening Event; Volunteer, 04/2005 – Present
Jewish Genetic Disease Education & Screening Event; ASU Campus, Volunteer, 10/2008
BRCATeers (Support Group for individuals with Hereditary Breast and Ovarian Cancer Syndrome); Co-Founder, 2005 - 2017
Heartbreaking Choices Support Group, Albuquerque NM; Facilitator, 1998 - 2000